Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-035951)

Filing Details

Accession Number:: 0001209191-14-035951
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-21 18:01:49
Reporting Period:: 2014-05-19

Filing Date:: 2014-05-21
Accepted Time:: 2014-05-21 18:01:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1206199	G Daniel Welch	3280 Bayshore Blvd Brisbane CA 94005	Charman, Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-19	11,607	$15.34	105,538	No	4	M	Direct
Common Stock	Disposition	2014-05-19	11,607	$38.00	93,931	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Stock Options	Common stock	Acquisiton	2014-05-19	4,219	$15.34	4,219	$15.34
Stock Options	Common stock	Acquisiton	2014-05-19	7,388	$15.34	7,388	$15.34

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
162,757	2010-12-13	2015-05-13	No	4	M	Direct
170,145	2011-12-13	2015-05-13	No	4	M	Direct

Footnotes

The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
Fully exercisable.